Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Ab™
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Khdrbs1em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Khdrbs1em1flox/Cya

Common Name
Khdrbs1-flox
Product ID
S-CKO-04911
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-20218-Khdrbs1-B6J-VA
Status
Research and Development
When using this mouse strain in a publication, please cite “Khdrbs1-flox Mouse (Catalog S-CKO-04911) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Khdrbs1-flox
Strain ID
CKOCMP-20218-Khdrbs1-B6J-VA
Gene Name
Khdrbs1
Product ID
S-CKO-04911
Gene Alias
p62, p68, Sam68
Background
C57BL/6JCya
Gene Full Name
KH domain containing, RNA binding, signal transduction associated 1
Modification
Conditional knockout
NCBI ID
20218 (Mouse)
Phenotype
MGI:893579
Chromosome
Chr 4 (Mouse)
Application
--
Datasheet
Click here to download >>
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000066257
NCBI Transcript ID
NM_011317
Target Region
Exon 2
Size of Effective Region
~1.9 kb
Overview of Gene Research
KHDRBS1, also known as Sam68, is an RNA-binding protein that plays crucial roles in multiple biological processes. It is involved in signal transduction and is associated with pathways such as NF-κB activation, which is important for cellular responses to DNA damage [3,5]. It also has a connection with the regulation of RNA stability and gene expression, influencing various biological functions [1,2]. Genetic models, like those in zebrafish, have been valuable in studying its functions [4].

In a zebrafish model of severe liver injury, khdrbs1 was found to be specifically expressed in bipotential progenitor cells (BPPCs). Loss-of-function experiments in zebrafish, using a CRISPR/dead Cas9-mediated system to interfere with khdrbs1 in biliary epithelial cells, led to defective liver regeneration and impaired re-differentiation of BPPCs. The khdrbs1-/-mutant showed impaired proliferation and re-differentiation of BPPCs, and this was associated with the activation of p53 signaling, as tp53 mutation could partially rescue the defective liver regeneration of the khdrbs1-/-mutant [4]. In mouse models, Sam68/KHDRBS1 deficiency abolished DNA damage-stimulated polymers of ADP-ribose (PAR) production and the PAR-dependent NF-κB transactivation of anti-apoptotic genes. Sam68 deleted cells were hypersensitive to genotoxicity, and knockdown of Sam68 sensitized human colon cancer cells to genotoxic stress-induced apoptosis, while genetic deletion of Sam68 dampened colon tumor burden in mice, indicating its role in colon tumorigenesis [5].

In conclusion, KHDRBS1 is essential for processes like liver regeneration in zebrafish and plays a significant role in colon tumorigenesis in mice. Its functions are mainly related to the regulation of cell-related processes such as re-differentiation, proliferation, and responses to genotoxic stress through its influence on signaling pathways like p53 and NF-κB. The use of gene-knockout models in zebrafish and mice has provided crucial insights into its role in these specific biological and disease-related processes.

References:
1. Wong, Tin-Lok, Loh, Jia-Jian, Lu, Shixun, Leung, Suet Yi, Ma, Stephanie. 2023. ADAR1-mediated RNA editing of SCD1 drives drug resistance and self-renewal in gastric cancer. In Nature communications, 14, 2861. doi:10.1038/s41467-023-38581-8. https://pubmed.ncbi.nlm.nih.gov/37208334/
2. Yu, Xin, Kang, Weibiao, Zhang, Jiajia, Chen, Changyu, Liu, Yi. 2022. Shortening of the KHDRBS1 3'UTR by alternative cleavage and polyadenylation alters miRNA-mediated regulation and promotes gastric cancer progression. In American journal of translational research, 14, 6574-6585. doi:. https://pubmed.ncbi.nlm.nih.gov/36247240/
3. Fu, Kai, Sun, Xin, Wier, Eric M, Hobbs, Ryan P, Wan, Fengyi. 2016. Sam68/KHDRBS1-dependent NF-κB activation confers radioprotection to the colon epithelium in γ-irradiated mice. In eLife, 5, . doi:10.7554/eLife.21957. https://pubmed.ncbi.nlm.nih.gov/27996939/
4. Gang, Kai, Chen, Qi, Sun, Junhui, Ni, Rui, Ma, Jianlong. 2025. Khdrbs1 drives re-differentiation of bipotential progenitor cells by inhibiting p53 in zebrafish biliary-mediated liver regeneration. In Development (Cambridge, England), 152, . doi:10.1242/dev.204266. https://pubmed.ncbi.nlm.nih.gov/39963927/
5. Fu, Kai, Sun, Xin, Wier, Eric M, Sears, Cynthia L, Wan, Fengyi. 2016. Sam68/KHDRBS1 is critical for colon tumorigenesis by regulating genotoxic stress-induced NF-κB activation. In eLife, 5, . doi:10.7554/eLife.15018. https://pubmed.ncbi.nlm.nih.gov/27458801/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research